Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV.

Glucagon-like peptide-1 7–36: a physiological incretin in man

Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91194-9 · Cited by 1,928

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

Nauck, M. A., Heimesaat, M. M., Orskov, C., Holst, J. J., Ebert, R., & Creutzfeldt, W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116186 · Cited by 1,651

Dipeptidyl‐peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon‐like peptide‐1(7–36)amide, peptide histidine methionine and is responsible for their degradation in human serum

MENTLEIN, R., GALLWITZ, B., & SCHMIDT, W. E. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17986.x · Cited by 1,161

Antidiabetogenic effect of glucagon-like peptide-1 (7–36)amide in normal subjects and patients with diabetes mellitus

Gutniak, M., Ørkov, C., Holst, J. J., Ahrén, B., & Efendić, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262003 · Cited by 868

Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing

Mojsov, S., Heinrich, G., Wilson, I. B., Ravazzola, M., Orci, L., & Habener, J. F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67324-7 · Cited by 724

Hamster preproglucagon contains the sequence of glucagon and two related peptides

Bell, G. I., Santerre, R. F., & Mullenbach, G. T. (1983) · Nature · doi:10.1038/302716a0 · Cited by 649

Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37)

Holz, G. G., Kiihtreiber, W. M., & Habener, J. F. (1993) · Nature · doi:10.1038/361362a0 · Cited by 591

Proline-Dependent Structural and Biological Properties of Peptides and Proteins

Yaron, A., Naider, F. R., & Scharpé, S. (1993) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239309082572 · Cited by 551

A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-?-naphthylamide

Hopsu-Havu, V. K., & Glenner, G. G. (1966) · Histochemistry and Cell Biology · doi:10.1007/bf00577838 · Cited by 437

Entero-Insular Axis

Unger, R. H. (1969) · Archives of Internal Medicine · doi:10.1001/archinte.1969.00300130043007 · Cited by 371

Surrogating and redirection of pyrazolo[1,5-a]pyrimidin-7(4H)-one core, a novel class of potent and selective DPP-4 inhibitors

Deng, X., Shen, J., Zhu, H., Xiao, J., Sun, R., Xie, F., Lam, C., Wang, J., Qiao, Y., Tavallaie, M. S., et al. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.01.006 · Cited by 25

Analogs of Glucose-Dependent Insulinotropic Polypeptide With Increased Dipeptidyl Peptidase IV Resistance

Kühn‐Wache, K., Manhart, S., Hoffmann, T., Hinke, S. A., Gelling, R. W., Pederson, R. A., Mclntosh, C. H. S., & Demuth, H. U. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46826-3_21 · Cited by 25

Dpp4 inhibition as a therapeutic strategy in cardiometabolic disease: Incretin-dependent and -independent function

Gong, Q., Rajagopalan, S., & Zhong, J. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.06.076 · Cited by 28

Glucagon-Like Peptide Receptor Agonist Inhibits Angiotensin II-Induced Proliferation and Migration in Vascular Smooth Muscle Cells and Ameliorates Phosphate-Induced Vascular Smooth Muscle Cells Calcification

Lee, J., Hong, S., Kim, M., Moon, S. J., Kwon, H., Park, S. E., Rhee, E., & Lee, W. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0363 · Cited by 25

The emerging role of the intestine in metabolic diseases

Bradley, W. D., Zwingelstein, C., & Rondinone, C. M. (2011) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2011.578651 · Cited by 24

The Place of GLP-1–Based Therapy in Diabetes Management: Differences Between DPP-4 Inhibitors and GLP-1 Receptor Agonists

Mize, D. L. E., & Salehi, M. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0377-9 · Cited by 24

Ligand Binding Pocket Formed by Evolutionarily Conserved Residues in the Glucagon-like Peptide-1 (GLP-1) Receptor Core Domain

Moon, M. J., Lee, Y.-N., Park, S., Reyes‐Alcaraz, A., Hwang, J., Millar, R. P., Choe, H., & Seong, J. Y. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.612606 · Cited by 24

Incretin-based Therapies for Type 2 Diabetes

McIntosh, C. H. S. (2008) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(08)22010-1 · Cited by 24

Specific Localization of Membrane Dipeptidase and Dipeptidyl Peptidase IV in Secretion Granules of Two Different Pancreatic Islet Cells

Grondin, G., Hooper, N. M., & LeBel, D. (1999) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549904700407 · Cited by 24

Prior Exercise and Postprandial Incretin Responses in Lean and Obese Individuals

Heden, T. D., Liu, Y., Kearney, M. L., Park, Y., Dellsperger, K. C., Thomas, T. R., & Kanaley, J. A. (2013) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318294b225 · Cited by 24

Ghrelin Inhibition Restores Glucose Homeostasis in Hepatocyte Nuclear Factor-1α (MODY3)–Deficient Mice

Brial, F., Lussier, C. R., Belleville, K., Sarret, P., & Boudreau, F. (2015) · Diabetes · doi:10.2337/db15-0124 · Cited by 24

Discovery of gastric inhibitory polypeptide and its subsequent fate: Personal reflections

Pederson, R. A., & McIntosh, C. H. S. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12480 · Cited by 24

Effects and mechanism of glucagon-like peptide-1 on injury of rats cardiomyocytes induced by hypoxia-reoxygenation

Xie, Y., Wang, S., Wei-wei, S. H. A., Zhou, X., Wang, W., Li-pin, H. A. N., Li, D., & Demin, Y. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200811010-00005 · Cited by 24

The design of potent and selective inhibitors of DPP-4: Optimization of ADME properties by amide replacements

Nordhoff, S., Bulat, S., Cerezo, S., Hill, O., Hoffmann-Enger, B., López-Canet, M., Rosenbaum, C., Rummey, C., Thiemann, M., Matassa, V. G., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.09.078 · Cited by 24

Antidiabetic Effects of Omega-3 Polyunsaturated Fatty Acids: From Mechanism to Therapeutic Possibilities

Iwase, Y., Kamei, N., & Takeda‐Morishita, M. (2015) · Pharmacology & Pharmacy · doi:10.4236/pp.2015.63020 · Cited by 25

Synthesis, bioactivity and specificity of glucagon-like peptide-1 (7–37)/polymer conjugate to isolated rat islets

Kim, S., Kim, S. W., & Bae, Y. H. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.09.045 · Cited by 24

Role of glucose in chronic desensitization of isolated rat islets and mouse insulinoma (betaTC-3) cells to glucose-dependent insulinotropic polypeptide

Hinke, S., Pauly, R., Ehses, J. A., Kerridge, P., Demuth, H.-U., McIntosh, C. H. S., & Pederson, R. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1650281 · Cited by 24

The interplay between leptin, glucocorticoids, and GLP1 regulates food intake and feeding behaviour

Perez‐Leighton, C. E., Kerr, B., Scherer, P. E., Baudrand, R. F., & Cortés, V. (2023) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.13039 · Cited by 22

Cardiovascular Effects of Incretins in Diabetes

Advani, A., Bugyei‐Twum, A., & Connelly, K. A. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.06.010 · Cited by 25

Selectivity of peptide ligands for the human incretin receptors expressed in HEK-293 cells

Al‐Sabah, S., Al-Fulaij, M. A., & Ahmed, H. A. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.08.019 · Cited by 23

A Cdk5 Inhibitor Enhances the Induction of Insulin Secretion by Exendin-4 Both in Vitro and in Vivo

Kitani, K., Oguma, S., Nishiki, T., Ohmori, I., Galons, H., Matsui, H., Meijer, L., & Tomizawa, K. (2007) · The Journal of Physiological Sciences · doi:10.2170/physiolsci.rp006607 · Cited by 23

Glucagon-like Peptide 1 Conjugated to Recombinant Human Serum Albumin Variants with Modified Neonatal Fc Receptor Binding Properties. Impact on Molecular Structure and Half-Life

Bukrinski, J. T., Sønderby, P., Antunes, F., Andersen, B., Schmidt, E. G. W., Peters, G. H. J., & Harris, P. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00492 · Cited by 22

Recent Developments in the Synthesis and Applications of Pyrazolidines. A Review

Davis, L. O. (2013) · Organic Preparations and Procedures International · doi:10.1080/00304948.2013.834769 · Cited by 23

Incretin-based therapies: new treatments for type 2 diabetes in the new millennium

Horowitz, M. (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s4975 · Cited by 23

In vivo inhibition of dipeptidyl peptidase IV activity by pro-pro-diphenyl-phosphonate (prodipine)

Meester, I. D., Belyaev, A. A., Lambeir, A., Meyer, G. R. Y. D., Osselaer, N. V., Haemers, A., & Scharpé, S. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00149-4 · Cited by 23

Aminomethylpyridines as DPP-IV inhibitors

Peters, J., Weber, S., Kritter, S., Weiss, P., Wallier, A., Zimmerli, D., Boehringer, M., Steger, M., & Loeffler, B. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.04.049 · Cited by 23

Effects of Aerobic Exercise with or without Metformin on Plasma Incretins in Type 2 Diabetes

Eshghi, S. R. T., Bell, G. J., & Boulé, N. G. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.030 · Cited by 22

Gut–brain cross-talk in appetite regulation

Cegla, J., Tan, T., & Bloom, S. R. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32833b64a3 · Cited by 23

Exendin-4 Treatment Expands Graft β-Cell Mass in Diabetic Mice Transplanted with a Marginal Number of Fresh Islets

Juang, J., Kuo, C.-H., Wu, C., & Juang, C. (2008) · Cell Transplantation · doi:10.3727/096368908786092766 · Cited by 22

Synthesis and biological evaluation of homopiperazine derivatives with β-aminoacyl group as dipeptidyl peptidase IV inhibitors

Ahn, J. H., Park, W. S., Jun, M. A., Shin, M. S., Kang, S. K., Kim, K. Y., Rhee, S. D., Bae, M. A., Kim, K. R., Kim, S. G., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.10.076 · Cited by 22

Incretin-Based Therapy and Type 2 Diabetes

Hare, K. J., & Knop, F. K. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00015-1 · Cited by 22

Synthesis, SAR, and atropisomerism of imidazolopyrimidine DPP4 inhibitors

O’Connor, S. P., Wang, Y., Simpkins, L. M., Brigance, R. P., Meng, W., Wang, A., Kirby, M., Weigelt, C. A., & Hamann, L. G. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.08.090 · Cited by 22

Newer therapeutic options for children with diabetes mellitus: theoretical and practical considerations

Jeha, G. S., & Heptulla, R. A. (2006) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2006.00159.x · Cited by 22

Alterations in Expression and in Serum Activity of Dipeptidyl Peptidase IV (DPP IV, CD26) in Patients with Hyporectic Eating Disorders

Hildebrandt, Rose, Mayr, Schuler, �., Reutter, Salama, & Klapp (1999) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1999.00612.x · Cited by 22

Eating disorders: a role for dipeptidyl peptidase IV in nutritional control

Hildebrandt, M., Rose, M., Mönnikes, H., Reutter, W. G., Keller, W., & Klapp, B. F. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00547-0 · Cited by 21

Exenatide

Lam, S., & See, S. (2006) · Cardiology in Review · doi:10.1097/01.crd.0000223655.16253.e4 · Cited by 22

The cysteine of the cytoplasmic tail of glucose-dependent insulinotropic peptide receptor mediates its chronic desensitization and down-regulation

Tseng, C., & Zhang, X. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00061-6 · Cited by 22

In Vitro Hypoglycemic Activities of Lactobacilli and Bifidobacterium Strains from Healthy Children’s Sources and Their Effect on Stimulating GLP-1 Secretion in STC-1 Cells

Cheng, Z., Chen, J., Zhang, Y., Li, X., Zhang, N., Liu, F., & Jiao, Y. (2024) · Foods · doi:10.3390/foods13040519 · Cited by 23

Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care

Caturano, A., Galiero, R., Rocco, M. P., Tagliaferri, G., Piacevole, A., Nilo, D., Lorenzo, G. D., Sardu, C., Vetrano, E., Monda, M., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12092039 · Cited by 25

Gut Hormones and Obesity

Scott, R., Tan, T., & Bloom, S. R. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-407766-9.00007-9 · Cited by 20

A novel exendin-4 human serum albumin fusion protein, E2HSA, with an extended half-life and good glucoregulatory effect in healthy rhesus monkeys

Zhang, L., Wang, L., Meng, Z., Gan, H., Gu, R., Wu, Z., Gao, L., Zhu, X., Sun, W., Li, J., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.045 · Cited by 21

2-({6-[(3R)-3-amino-3-methylpiperidine-1-yl]-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-5H-pyrrolo[3,2-d]pyrimidine-5-yl}methyl)-4-fluorobenzonitrile (DSR-12727): A potent, orally active dipeptidyl peptidase IV inhibitor without mechanism-based inactivation of CYP3A

Nishio, Y., Kimura, H., Sawada, N., Sugaru, E., Horiguchi, M., Ono, M., Furuta, Y., Sakai, M., Masui, Y., Otani, M., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.07.042 · Cited by 21

The effects of food components on hormonal signalling in gastrointestinal enteroendocrine cells

Bruen, C. M., O’Halloran, F., Cashman, K. D., & Giblin, L. (2012) · Food & Function · doi:10.1039/c2fo30086a · Cited by 21

Incretin mimetics and dipeptidyl peptidase-4 inhibitors: innovative treatment therapies for type 2 diabetes

Davidson, J. A., Parente, E. B., & Gross, J. L. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000600016 · Cited by 21

Physiologic and Neural Controls of Eating

Moran, T. H., & Ladenheim, E. E. (2016) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.07.009 · Cited by 22

Function of a long‐term, GLP‐1‐treated, insulin‐secreting cell line is improved by preventing DPP IV‐mediated degradation of GLP‐1

Green, B., Liu, H. K., McCluskey, J. T., Duffy, N. A., O'Harte, F. P. M., McClenaghan, N. H., & Flatt, P. R. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00430.x · Cited by 21

Effects on glucose homeostasis and insulin secretion of long term activation of the glucose-dependent insulinotropic polypeptide (GIP) receptor by N-AcGIP(LysPAL37) in normal mice

Irwin, N., Green, B. D., Gault, V. A., Cassidy, R. S., O'Harte, F. P. M., Harriott, P., & Flatt, P. R. (2005) · Peptides · doi:10.1016/j.peptides.2005.08.003 · Cited by 21

Structure-Activity Relationships of Glucose-Dependent Insulinotropic Polypeptide (GIP)

Hinke, S. A., Gelling, R. W., Manhart, S., Lynn, F. C., Pederson, R. A., Kühn‐Wache, K., Rosche, F., Demuth, H., Coy, D. H., & McIntosh, C. H. S. (2003) · Biological Chemistry · doi:10.1515/bc.2003.046 · Cited by 22

Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors

Tsai, T., Coumar, M. S., Hsu, T., Hsieh, H., Chien, C., Chen, C.-T., Chang, C., Lo, Y.-K., Wu, S., Huang, C., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.03.037 · Cited by 21

Neuroendocrine Peptides of the Gut and Their Role in the Regulation of Food Intake

Schalla, M. A., Taché, Y., & Stengel, A. (2021) · Comprehensive physiology · doi:10.1002/cphy.c200007 · Cited by 28

Physiological Appetite Regulation and Bariatric Surgery

Ramasamy, I. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051347 · Cited by 21

The rollercoaster history of using physiological and pharmacological properties of incretin hormones to develop diabetes medications with a convincing benefit-risk relationship

Nauck, M. A. (2019) · Metabolism · doi:10.1016/j.metabol.2019.154031 · Cited by 21

RISING STARS: Endocrine regulation of metabolic homeostasis via the intestine and gut microbiome

Meyer, R. K., & Duca, F. A. (2023) · Journal of Endocrinology · doi:10.1530/joe-23-0019 · Cited by 25

Impact of the Dipeptidyl Peptidase-4 Inhibitor Vildagliptin on Glucose Tolerance and β-Cell Function and Mass in Insulin Receptor Substrate-2-Knockout Mice Fed a High-Fat Diet

Sato, K., Nakamura, A., Shirakawa, J., Muraoka, T., Togashi, Y., Shinoda, K., Orime, K., Kubota, N., Kadowaki, T., & Terauchi, Y. (2012) · Endocrinology · doi:10.1210/en.2011-1712 · Cited by 20

Synthesis, biological assay in vitro and molecular docking studies of new imidazopyrazinone derivatives as potential dipeptidyl peptidase IV inhibitors

Zhu, Y., Xia, S., Zhu, M., Yi, W., Cheng, J., Song, G., Li, Z., & Lü, P. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.08.002 · Cited by 20

Feedback suppression of meal‐induced glucagon‐like peptide‐1 ( GLP ‐1) secretion mediated through elevations in intact GLP ‐1 caused by dipeptidyl peptidase‐4 inhibition: a randomized, prospective comparison of sitagliptin and vildagliptin treatment

Baranov, O., Kahle, M., Deacon, C. F., Holst, J. J., & Nauck, M. A. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12706 · Cited by 20

The role of linagliptin, a selective dipeptidyl peptidase-4 inhibitor, in the morphine rewarding effects in rats

Łupina, M., Talarek, S., Kotlinska, J. H., Gibuła‐Tarłowska, E., Listos, P., & Listos, J. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104616 · Cited by 21

Development of a robust QSAR model to predict the affinity of pyrrolidine analogs for dipeptidyl peptidase IV (DPP- IV)

Paliwal, S., Seth, D., Yadav, D., Yadav, R., & Paliwal, S. (2011) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756361003777057 · Cited by 20

High-Level Expression of Fusion Protein Containing 10 Tandem Repeated GLP-1 Analogs in YeastPichia pastorisand Its Biological Activity in a Diabetic Rat Model

Hou, J., Yan, R., Yang, L., Wu, Z., Cuiyan, W. A. N. G., Ding, D., Li, N., Ma, C., & Li, M. (2007) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.60694 · Cited by 20

Dipeptidyl Peptidase IV Inhibition in Animal Models of Diabetes

Pospisilik, J. A., Ehses, J. A., Doty, T., McIntosh, C. H. S., Demuth, H., & Pedersohn, R. A. (2004) · Advances in experimental medicine and biology · doi:10.1007/0-306-47920-6_34 · Cited by 20

Stable agonist of glucose-dependent insulinotropic polypeptide (GIP) restores pancreatic beta cell glucose responsiveness but not glucose intolerance in aging mice

Irwin, N., Green, B. D., Gault, V. A., Harriott, P., O'Harte, F. P. M., & Flatt, P. R. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.11.006 · Cited by 20

Modern antidiabetic therapy by sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 receptor agonists, and dipeptidyl peptidase 4 inhibitors against cardiovascular diseases

Steven, S., Kuntić, M., Münzel, T. F., & Daiber, A. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100082 · Cited by 24

Recent Approaches for Bioactive Peptides Production from Pulses and Pseudocereals

Martoccia, M., Disca, V., Jaouhari, Y., Coïsson, J. D., & Bordiga, M. (2025) · Molecules · doi:10.3390/molecules30214304 · Cited by 19

Simultaneous quantification of intracellular and secreted active and inactive glucagon-like peptide-1 from cultured cells

Amao, M., Kitahara, Y., Tokunaga, A., Shimbo, K., Eto, Y., & Yamada, N. (2014) · Analytical Biochemistry · doi:10.1016/j.ab.2014.11.009 · Cited by 19

Stabilized β-Hairpin Peptide Inhibits Insulin Degrading Enzyme

Yang, D., Qin, W., Shi, X., Zhu, B., Xie, M., Zhao, H., Teng, B., Wu, Y., Zhao, R., Yin, F., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00418 · Cited by 19

Las hormonas gastrointestinales en el control de la ingesta de alimentos

Álvarez-Crespo, M., González-Matías, L. C., Gil‐Lozano, M., Paz, S. F., Romaní‐Pérez, M., Gago, E. M., & Ferrer, F. M. (2009) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(09)71946-1 · Cited by 22

The efficacy and safety of exenatide once weekly in patients with type 2 diabetes

Heimbürger, S. M. N., Brønden, A., Johansen, N. J., Dejgaard, T. F., Vilsbøll, T., & Knop, F. K. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1571040 · Cited by 20

Neutral Endopeptidase 24.11 and Dipeptidyl Peptidase IV are Both Involved in Regulating the Metabolic Stability of Glucagon-like Peptide-1 in vivo

Plamboeck, A., Holst, J. J., Carr, R. D., & Deacon, C. F. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47920-6_36 · Cited by 20

Identification of diverse dipeptidyl peptidase IV inhibitors via structure-based virtual screening

Cui, L., Lü, W., Lü, C., Xiao, W. J., Shen, X., Huang, J. Y., Liu, G., & Tang, Y. (2012) · Journal of Molecular Modeling · doi:10.1007/s00894-012-1394-3 · Cited by 19

Focus on Incretin-Based Therapies: Targeting the Core Defects of Type 2 Diabetes

Jellinger, P. S. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.01.2245 · Cited by 21

[Ser2]- and [Ser(P)2]Incretin Analogs

Hinke, S. A., Manhart, S., Kühn‐Wache, K., Nian, C., Demuth, H., Pederson, R. A., & McIntosh, C. H. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311304200 · Cited by 19

Incretin hormones and insulin sensitivity

Hansen, P. A., & Corbett, J. A. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.03.002 · Cited by 19

A Radioimmunoassay for LY315902 an analog of Glucagon-like Insulinotropic Peptide, and Its Application in the Study of Canine Pharmacokinetics

Chou, J., Place, G. D., Waters, D. G., Kirkwood, J. A., & Bowsher, R. R. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js9700560 · Cited by 19

Metabolite Identification of Therapeutic Peptides and Proteins by Top-down Differential Mass Spectrometry and Metabolite Database Matching.

Yu, X., Fridman, A., Bagchi, A., Xu, S., Kwasnjuk, K., Lu, P., & Cancilla, M. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c00652 · Cited by 10

The intestine and the microbiota in maternal glucose homeostasis during pregnancy

Yeo, E., Brubaker, P. L., & Sloboda, D. M. (2022) · Journal of Endocrinology · doi:10.1530/joe-21-0354 · Cited by 20

Novel Pharmaceuticals in Appetite Regulation: Exploring emerging gut peptides and their pharmacological prospects

Rubinić, I., Kurtov, M., & Likić, R. (2024) · Pharmacology Research & Perspectives · doi:10.1002/prp2.1243 · Cited by 23

Glucagon-like peptide-1 (7–36) but not (9–36) augments cardiac output during myocardial ischemia via a Frank–Starling mechanism

Goodwill, A. G., Tune, J. D., Noblet, J. N., Conteh, A. M., Sassoon, D., Casalini, E. D., & Mather, K. J. (2014) · Basic Research in Cardiology · doi:10.1007/s00395-014-0426-9 · Cited by 18

Colonic delivery of docosahexaenoic acid improves impaired glucose tolerance via GLP-1 secretion and suppresses pancreatic islet hyperplasia in diabetic KK-Ay mice

Shida, T., Kamei, N., Takeda‐Morishita, M., Isowa, K., & Takayama, K. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.04.029 · Cited by 18

Harnessing the incretin system beyond glucose control: Potential cardiovascular benefits of GLP-1 receptor agonists in type 2 diabetes

Cariou, B. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.04.003 · Cited by 18

Insulin‐dependent phosphorylation of DPP IV in liver

Bilodeau, N., Fiset, A., Poirier, G. G., Fortier, S., Gingras, M., Lavoie, J. N., & Faure, R. L. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05125.x · Cited by 18

Design and Synthesis of 4‐(2,4,5‐Trifluorophenyl)butane‐1,3‐diamines as Dipeptidyl Peptidase IV Inhibitors

Zhu, L., Li, Y., Qiu, L., Su, M., Wang, X., Xia, C., Qu, Y., Li, J., Li, J., Xiong, B., et al. (2013) · ChemMedChem · doi:10.1002/cmdc.201300104 · Cited by 18

Prolonged GIP receptor activation using stable mini-PEGylated GIP improves glucose homeostasis and beta-cell function in age-related glucose intolerance

Kerr, B. D., Irwin, N., Flatt, P. R., & Gault, V. A. (2008) · Peptides · doi:10.1016/j.peptides.2008.10.017 · Cited by 18

Methods for the investigation of neuropeptide catabolism and stability in vitro

Mentlein, R., & Lucius, R. (1997) · Brain Research Protocols · doi:10.1016/s1385-299x(96)00035-9 · Cited by 18

Long-Acting GLP-1 Analogue in V-Shaped Conformation by Terminal Polylysine Modifications

Yang, X., Li, Y., Wang, Y., Zheng, X., Kong, W., Meng, F., Zhou, Z., Liu, C., Li, Y., & Gong, M. (2014) · Molecular Pharmaceutics · doi:10.1021/mp5002685 · Cited by 17

Enterohormone therapy for short bowel syndrome

Verbiest, A., Wauters, L. I., & Vanuytsel, T. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000710 · Cited by 17

The Effectiveness of Antidiabetic Drugs in Treating Dementia: A Peek into Pharmacological and Pharmacokinetic Properties

Ogura, J., & Yamaguchi, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126542 · Cited by 19

Design and Development of a New Glucagon-Like Peptide-1 Receptor Agonist to Obtain High Oral Bioavailability

Chen, H., Lu, Y., Shi, S., Zhang, Q., Cao, X., Sun, L., An, D., Zhang, X., Kong, X., & Liu, J. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03265-3 · Cited by 18

Hydrogen sulfide reduces oxidative stress in Huntington’s disease via Nrf2

Jiang, Z., Liu, D., Li, T., Gai, C., Xin, D., Zhao, Y., Song, Y., Cheng, Y., Li, T., & Wang, Z. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01051 · Cited by 17

Reduction of blood glucose and HbA1c levels by cyanidin 3,5-diglucoside in KKAy mice

Yamane, T., Imai, M., Handa, S., Yamada, K., Sakamoto, T., Ishida, T., Inui, H., Yamamoto, Y., Nakagaki, T., & Nakano, Y. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.04.038 · Cited by 17

A novel approach to treating opioid use disorders: Dual agonists of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors

Merkel, R., Moreno, A., Zhang, Y., Herman, R. J., Nathan, J. B., Zeb, S., Rahematpura, S., Stecyk, K. S., Milliken, B. T., Hayes, M. R., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.10.026 · Cited by 17

Study on preparation and activity of a novel recombinant human parathyroid hormone(1–34) analog with N-terminal Pro–Pro extension

Chunxiao, W., Liu, J., Yire, X., Ding, M., Wang, Z., Qi, G., Xiangchun, S., Xue-jun, W., Wu, J., & Li, T. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2006.12.020 · Cited by 17

3D-QSAR studies of dipeptidyl peptidase-4 inhibitors using various alignment methods

Patel, B., & Ghate, M. D. (2014) · Medicinal Chemistry Research · doi:10.1007/s00044-014-1178-7 · Cited by 17

Evidence for an interaction between leptin, T cell costimulatory antigens CD28, CTLA-4 and CD26 (dipeptidyl peptidase IV) in BCG-induced immune responses of leptin- and leptin receptor-deficient mice

Rüter, J., Hoffmann, T., Demuth, H. U., Moschansky, P., Klapp, B. F., & Hildebrandt, M. (2004) · Biological Chemistry · doi:10.1515/bc.2004.063 · Cited by 17

Antidiabetic effects of dipeptidyl peptidase–IV inhibitors and sulfonylureas in streptozotocin-nicotinamide–induced mildly diabetic mice

Matsuyama‐Yokono, A., Tahara, A., Nakano, R., Someya, Y., Shiraki, K., Hayakawa, M., & Shibasaki, M. (2009) · Metabolism · doi:10.1016/j.metabol.2008.10.012 · Cited by 18

CD26/DPPIV cell membrane expression and DPPIV activity in plasma of patients with acute leukemia

Andrade, C., Bigni, R., Pombo‐de‐Oliveira, M. S., Alves, G., & Pereira, D. D. A. (2009) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360802334800 · Cited by 17

Insulin combined with C hinese medicine improves glycemic outcome through multiple pathways in patients with type 2 diabetes mellitus

Zhang, X., Liu, Y., Xiong, D., & Xie, C. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12352 · Cited by 16

Synthesis of (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile: A key intermediate for dipeptidyl peptidase IV inhibitors

Singh, S. K., Manne, N., & Pal, M. (2008) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.4.20 · Cited by 17

Emerging technologies to achieve oral delivery of GLP-1 and GLP-1 analogs for treatment of type 2 diabetes mellitus (T2DM)

Ma, S., We, L., Yang, H., Deng, S., & Jevnikar, A. M. (2017) · Canadian Journal of Biotechnology · doi:10.24870/cjb.2017-000107 · Cited by 17

Role and development of GLP-1 receptor agonists in the management of diabetes

Egan, J. M., & Chia, C. W. (2009) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s4283 · Cited by 19

Degradation of glucosedependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 136:3585e3596

McIntosh, C. H. S., Widenmaier, S. B., & Kim, S.-J. (1995)

Investigation of metabolism of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) by dipeptidyl peptidase IV (DP IV)

Pauly, R. P. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0087239

Preservation of active incretin hormones by inhibition of dipeptidyl peptidase IV suppresses meal-induced incretin secretion in dogs

Deacon, C. F., Wamberg, S., Bie, P., Hughes, T., & Holst, J. J. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1720355 · Cited by 146

The enteroinsular axis in dipeptidyl peptidase IV-negative rats

Pederson, R. A., Kieffer, T. J., Pauly, R. P., Kofod, H., Kwong, J., & McIntosh, C. H. S. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90112-2 · Cited by 49

Dipeptidyl Peptidase IV Inhibition Reduces the Degradation and Clearance of GIP and Potentiates Its Insulinotropic and Antihyperglycemic Effects in Anesthetized Pigs

Deacon, C. F., Danielsen, P. L., Klarskov, L., Olesen, M., & Holst, J. J. (2001) · Diabetes · doi:10.2337/diabetes.50.7.1588 · Cited by 145